UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia

PloS one, 2019-03, Vol.14 (3), p.e0212837

2019

Volltextzugriff (PDF)

Long-term effects of malnutrition on severity of COVID-19

Scientific reports, 2021-07, Vol.11 (1), p.14974-8, Article 14974

2021

Volltextzugriff (PDF)

A Case of Lemierre Syndrome in the Era of COVID-19: All That Glitters Is Not Gold

The Pediatric infectious disease journal, 2020-12, Vol.39 (12), p.e445-e447

2020

Volltextzugriff (PDF)

Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents

The Pediatric infectious disease journal, 2016-06, Vol.35 (6), p.628-633

2016

Volltextzugriff (PDF)

Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia

The Pediatric infectious disease journal, 2018-09, Vol.37 (9), p.893-900

2018

Volltextzugriff (PDF)

Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Antimicrobial agents and chemotherapy, 2021-07, Vol.65 (8), p.e0029021

2021

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection

The Pediatric infectious disease journal, 2018-11, Vol.37 (11), p.1130-1136

2018

Volltextzugriff (PDF)

Pharmacokinetics, Safety, and Tolerability of Single‐Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study

Journal of clinical pharmacology, 2019-05, Vol.59 (5), p.654-667

2019

Volltextzugriff (PDF)

Safety of micafungin in pediatric clinical trials

The Pediatric infectious disease journal, 2011-06, Vol.30 (6), p.e97-e102

2011

Volltextzugriff (PDF)

Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults

Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5770-5779

2011

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

Antimicrobial Agents and Chemotherapy, 2005-08, Vol.49 (8), p.3317-3324

2005

Volltextzugriff (PDF)

Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US

JAMA network open, 2022-05, Vol.5 (5), p.e2211967-e2211967

2022

Volltextzugriff (PDF)

Population Pharmacokinetics of Micafungin in Pediatric Patients and Implications for Antifungal Dosing

Antimicrobial Agents and Chemotherapy, 2007-10, Vol.51 (10), p.3714-3719

2007

Volltextzugriff (PDF)

Listeria Meningitis After Infliximab Treatment of Ulcerative Colitis

Journal of pediatric gastroenterology and nutrition, 2010-03, Vol.50 (3), p.337-339

2010

Volltextzugriff (PDF)

The impact of the central venous catheter on the diagnosis of infectious endocarditis using Duke criteria in children with Staphylococcus aureus bacteremia

The Pediatric infectious disease journal, 2008-07, Vol.27 (7), p.636-639

2008

Volltextzugriff (PDF)

Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients

The American journal of surgery, 2007-09, Vol.194 (3), p.367-374

2007

Volltextzugriff (PDF)

Safety and Antibody Kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients

The Pediatric infectious disease journal, 2021-07, Vol.40 (7), p.606-611

2021

Volltextzugriff (PDF)

Daptomycin for Complicated Skin Infections: A Randomized Trial

Pediatrics (Evanston), 2017-03, Vol.139 (3)

2017

Volltextzugriff (PDF)

Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial

The Pediatric infectious disease journal, 2008-09, Vol.27 (9), p.820-826

2008

Volltextzugriff (PDF)

Multi‐institutional experience with COVID‐19 convalescent plasma in children

Transfusion (Philadelphia, Pa.), 2023-05, Vol.63 (5), p.918-924

2023

Volltextzugriff (PDF)

Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates

The Pediatric infectious disease journal, 2012-12, Vol.31 (12), p.1252-1257

2012

Volltextzugriff (PDF)

Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation

Journal of pediatric hematology/oncology, 2015-01, Vol.37 (1), p.e45-e50

2015

Volltextzugriff (PDF)

Pharmacokinetics of micafungin in pediatric patients with invasive candidiasis and candidemia

The Pediatric infectious disease journal, 2012-06, Vol.31 (6), p.630-632

2012

Volltextzugriff (PDF)

A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age

The Pediatric infectious disease journal, 2019-03, Vol.38 (3), p.275-279

2019

Volltextzugriff (PDF)

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents

Antimicrobial agents and chemotherapy, 2015-02, Vol.59 (2), p.905-913

2015

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(41)

Sprache

Englisch
(40)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(41)
Science & Technology
(40)
Life Sciences & Biomedicine
(38)
Child
(35)
Male
(31)
Child, Preschool
(30)
Female
(30)
Pediatrics
(26)
Infant
(22)
Infectious Diseases
(19)
Immunology
(17)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Treatment Outcome
(13)
Pharmacology. Drug Treatments
(11)
Adult
(10)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(10)
Pediatric
(10)
Antifungal Agents
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia

Long-term effects of malnutrition on severity of COVID-19

A Case of Lemierre Syndrome in the Era of COVID-19: All That Glitters Is Not Gold

Pharmacokinetics, Safety and Tolerability of Single Oral or Intravenous Administration of 200 mg Tedizolid Phosphate in Adolescents

Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia

Safety, Tolerability, and Population Pharmacokinetics of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane/Tazobactam in Children With Proven or Suspected Gram-Negative Infection

Pharmacokinetics, Safety, and Tolerability of Single‐Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study

Safety of micafungin in pediatric clinical trials

Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults

Safety, Tolerability, and Pharmacokinetics of Micafungin (FK463) in Febrile Neutropenic Pediatric Patients

Association of Congenital and Acquired Cardiovascular Conditions With COVID-19 Severity Among Pediatric Patients in the US

Population Pharmacokinetics of Micafungin in Pediatric Patients and Implications for Antifungal Dosing

Listeria Meningitis After Infliximab Treatment of Ulcerative Colitis

The impact of the central venous catheter on the diagnosis of infectious endocarditis using Duke criteria in children with Staphylococcus aureus bacteremia

Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients

Safety and Antibody Kinetics of COVID-19 Convalescent Plasma for the Treatment of Moderate to Severe Cases of SARS-CoV-2 Infection in Pediatric Patients

Daptomycin for Complicated Skin Infections: A Randomized Trial

Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial

Multi‐institutional experience with COVID‐19 convalescent plasma in children

Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates

Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation

Pharmacokinetics of micafungin in pediatric patients with invasive candidiasis and candidemia

A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age

Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents

Aktive Filter

Suchergebnisse filtern